Cortisone Shots for Neck Pain
Prospective Observational Trial of Intra-Articular Cervical Zygapophyseal Joint Corticosteroid Injections in Patients With Increased Peri-Zygapophyseal Joint MRI Short Tau Inversion Recovery Signal
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304
- Stanford University
-
Redwood City, California, United States, 94063
- Stanford University
-
-
Tennessee
-
Nashville, Tennessee, United States, 37212
- Vanderbilt University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- at least 18 years old
- Patient who will be getting a neck cortisone shot for pain that has been there for at least 4 weeks
- A specific MRI finding (increased Short Tau Inversion Recovery signal) around 1 or more of the joints in the neck
Exclusion Criteria:
- Those receiving disability, worker's compensation, or are involved in litigation related to their pain.
- Those unable to read English and complete the assessment instruments.
- Those unable to attend follow up appointments
- The patient is incarcerated.
- Grade 2 or greater spondylolisthesis at the involved or adjacent segments.
- History of prior posterior cervical surgery. Anterior cervical surgery is not an exclusion criteria.
- Progressive motor deficit, and/or clinical signs of myelopathy.
- Prior neck cortisone shots within the past 6 months.
- Possible pregnancy or other reason that precludes the use of fluoroscopy.
- Allergy to contrast media or local anesthetics.
- BMI>35.
- Systemic inflammatory arthritis (e.g., rheumatoid arthritis, ankylosing spondylitis, lupus).
- Active infection or treatment of infection with antibiotics within the past 7 days.
- Chronic widespread pain or somatoform disorder (e.g. fibromyalgia).
- Addictive behavior, severe clinical depression, or psychotic features.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Numeric Pain Rating Scale
Time Frame: Baseline, 2-4 weeks, and 3 months
|
0 to 10 scale grading severity of pain
|
Baseline, 2-4 weeks, and 3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neck Disability Index
Time Frame: Baseline, 2-4 weeks, and 3 months
|
Measure of neck pain related disability, scored between 0-50 with 0 being no disability and higher numbers being higher levels of disability
|
Baseline, 2-4 weeks, and 3 months
|
|
Work status
Time Frame: Baseline, 2-4 weeks, and 3 months
|
Yes or No explaining if the patient is working
|
Baseline, 2-4 weeks, and 3 months
|
|
Medication use
Time Frame: Baseline, 2-4 weeks, and 3 months
|
Yes or No explaining if the patient is taking pain medication
|
Baseline, 2-4 weeks, and 3 months
|
|
Use of other treatments
Time Frame: Baseline, 2-4 weeks, and 3 months
|
Yes or No explaining if the patient is using other health care resources
|
Baseline, 2-4 weeks, and 3 months
|
|
Global Assessment of Change
Time Frame: 2-4 weeks and 3 months
|
Question asking if the patient is improved, the same, or worse
|
2-4 weeks and 3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IRB-45400
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.